The Medicines (Products Other Than Veterinary Drugs) (Prescription Only) Amendment Order 1988

Citation, interpretation and commencement

1.  This Order, which may be cited as the Medicines (Products Other Than Veterinary Drugs) (Prescription Only) Amendment Order 1988, amends the Medicines (Products Other Than Veterinary Drugs) (Prescription Only) Order 1983(1) (hereinafter referred to as “the principal Order”) and shall come into force on 16th December 1988.

Amendment of article 4 of the principal Order

2.  In article 4 of the principal Order (medicinal products that are not prescription only) —

(a) the following paragraph is inserted after paragraph (1A) —

“(1B) Notwithstanding Article 3(1)(a), a medicinal product shall not be a prescription only medicine by reason that it consists of or contains the substance astemizole where—

(a) it is for oral use;

(b) it is not a sustained release preparation;

(c) it is sold or supplied in a container or package containing not more than 100mg;

(d) it is indicated only for the treatment of hay fever in adults or in children over the age of 12 years; and

(e) its container or package is labelled to show a maximum daily dose of 10mg.”;

(b) the following paragraph is substituted for paragraph (3) —

“(3) Notwithstanding Article 3(1)(d), any preparation of insulin for parenteral administration to human beings shall not be a prescription only medicine.”.

Insertion of article 11A into the principal Order

3.  The following article is inserted after article 11 of the principal Order:—

“Exemption in the case of a forged prescription

11A.   The restrictions imposed by section 58(2)(a) (restrictions on sale and supply) shall not apply to the sale or supply of a prescription only medicine by a pharmacist in accordance with a forged prescription where the pharmacist, having exercised all due diligence, believes on reasonable grounds that the prescription is genuine.”.

Amendment of Part I of Schedule 1 to the principal Order

4.  In Part I of Schedule 1 to the principal Order (which lists substances which render a medicinal product a prescription only medicine except in circumstances also listed) —

(a) the following substances are inserted at the appropriate point in the alphabetical order of the substances listed in Column 1—

• “Alclometasone Dipropionate

• Astemizole

• Auranofin

• Buspirone Hydrochloride

• Ciprofloxacin

• Ciprofloxacin Hydrochloride

• Clavulanic Acid

• Danthron

• Desogestrel

• Disodium Etidronate

• Etodolac

• Gemeprost

• Mesalazine

• Metergoline

• Mupirocin

• Nabumetone

• Nicardipine Hydrochloride

• Potassium Clavulanate

• Somatrem

• Sulbactam Sodium

• Thiabendazole

• Trientine Dihydrochloride

• Zidovudine

• Zuclopenthixol Hydrochloride”;

(b) the following substances in Column 1 are deleted —

• “Chlordiazepoxide Hydrochloride

• Etidronate Disodium

• Potassium Clorazepate”;

(c) in Column 3 of the entry relating to Amodiaquine Hydrochloride, the words “Prophylaxis of malaria” are deleted;

(d) for the entry relating to Ibuprofen there is substituted the entry set out in the Schedule to this Order.

Amendment of Part III of Schedule 1 to the principal Order

5.  In Part III of Schedule 1 to the principal Order (medicinal products, specified by name and product licence number, which are prescription only medicines), the following entry is deleted:—

• “Cedocard 20

  0424/0036”

Amendment of Part IV of Schedule 1 to the principal Order.

6.  In Part IV of Schedule 1 to the principal Order (specified medicinal products that are not prescription only medicines) —

(a) the heading “TABLE A” is inserted above the words “NAME AND PRODUCT LICENCE NUMBER OF MEDICINAL PRODUCTS THAT ARE NOT PRESCRIPTION ONLY MEDICINES”;

(b) the following entries are inserted at the appropriate point in the alphabetical order of medicinal products already listed therein —

• “Anflam Cream 0.5%

  0142/0263

• Anflam Ointment 0.5%

  0142/0262

• Dermacort Hydrocortisone Cream

  8265/0002”.

(c) the following Table is inserted at the end of the list of medicinal products already listed therein —

“TABLE B

RELEVANT PRODUCT LICENCE HOLDER AND NAME AND PRODUCT LICENCE NUMBER OF MEDICINAL PRODUCTS THAT ARE NOT PRESCRIPTION ONLY MEDICINES

Leo Laboratories Limited: Hydrocortisone Acetate Cream BP 0.5% — 0043/0150 Hydrocortisone Acetate Cream BP 1.0% — 0043/0151

Richard Daniel and Son Limited: Hydrocortisone Cream BP 1.0% — 0842/0011”.

Signed by authority of the Secretary of State for Health.

D. Mellor

Minister of State,

Department of Health

7th November 1988

Peter Walker

Secretary of State for Wales

9th November 1988

Malcolm Rifkind

Secretary of State for Scotland

10th November 1988

In Witness whereof the Official Seal of the Minister of Agriculture, Fisheries and Food is hereunto affixed on 16th November 1988.

John MacGregor

Minister of Agriculture, Fisheries and Food

Sealed with the Official Seal of the Department of Health and Social Services for Northern Ireland this 14th day of November 1988.

F. A. Elliott

Permanent Secretary

Sealed with the Official Seal of the Department of Agriculture for Northern Ireland this 14th day of November 1988.

W. H. Jack

Permanent Secretary